Diroximel fumarate in patients with relapsing–remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study

B. Singer, Sibyl Wray, Jiwon Oh et al.|Multiple Sclerosis Journal|2023

Cited by 23